Shasun Pharma Gets US Regulator's Nod for Pain Relief Drug
Business | Press Trust of India | Monday November 16, 2015
Shasun Pharmaceuticals on Monday said it has received approval of the US Food and Drug Administration (FDA) nod to market pain relief drug Carisoprodol in the US.
Strides Arcolab Recovers After Falling Over 5%
Business | Thursday June 18, 2015
Shares of Strides Arcolab slumped 5.4 per cent to Rs 1,090.80 on the BSE after the government rejected a proposal of the pharmaceutical company.
Shasun Pharma, Strides Arcolab Gain on CCI's Nod for Merger
Business | Tuesday March 24, 2015
The combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 15 listed drug makers.
Shasun Gets Investors' Nod for Strides Arcolab Merger
Business | Tuesday March 17, 2015
Shareholders of Shasun Pharmaceuticals have approved its merger proposal with drug firm Strides Arcolab.
Strides Arcolab Gains 11%; Board Approves Merger With Shasun Pharma
Business | Monday September 29, 2014
Under the scheme of merger Shasun Pharmaceuticals will amalgamate with Strides in an all-stock transaction. Shareholder of Shasun Pharmaceuticals will receive 5 equity shares of Strides for every 16 equity shares held by them in Shasun.
Shasun Pharmaceuticals Gains Nearly 30% in Three Days
Business | Thursday May 8, 2014
According to the bulk deal data of NSE, Morgan Stanley Asia (Singapore) PTE bought 402,545 shares for Rs 146.86 per equity share.
Shasun Pharma Acquires Global Rights for Ibuprofen from ScolorPharma
Business | Monday May 5, 2014
The acquisition also includes the controlled release technology of Ibuprofen 12-hour extended release OTC, the company said in a statement.
Ascent Capital buys minority stake in Alivira Animal Health
Business | Wednesday April 16, 2014
Shasun Pharmaceuticals on Wednesday said private equity investor Ascent Capital Advisors India has acquired a minority stake in Alivira Animal Health, a JV firm in which the company and Sequent Scientific Ltd are partners.
Shasun Pharmaceuticals falls on Vertex drug warning
Business | Thursday December 20, 2012
Shasun Pharmaceuticals declined 6 percent after its Vertex Pharmaceuticals warned on Wednesday its hepatitis C drug Incivek, which is used in conjunction with two other products, can cause serious, potentially fatal skin reactions.
SHASUN PHARMACEUTICALS LTD. - Notice of Postal Ballot
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that members of the Company will consider the resolutions by way of Postal Ballot.
Shasun Pharmaceuticals Limited - Change in Directorate
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that the following changes in the Board of Directors of the Company with effective from August 19, 2011; 1. Mr. Tapan Ray, Independent Director & Mr. V. F. Banaji, Independent Director have resigned. 2. Mr. N. Subramanian is inducted as independent Director. 3. Mr. M. Mohan is inducted as Wholetime Di...
Shasun Pharmaceuticals Limited - Outcome of Board Meeting
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 19, 2011, decided to issue and allot 15,00,000 warrants on preferential basis to Promoters / Promoter Group(s) and Directors with each warrant convertible into one equity share of the Company as per the SEBI Guidelines and subject to...
Shasun Pharmaceuticals Ltd - Fixes Book Closure for Dividend & AGM
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 22, 2011 to July 29, 2011 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on July 29, 2011.
Shasun Pharmaceuticals Ltd - Change in Directorate
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that Mr. A. Mahendran has resigned from the Directorship of the Company and Mr. R Sundara Rajan is appointment as Director with effect from May 30, 2011. The changes have been recorded and approved at the Board of Directors' Meeting held on May 30, 2011.
Shasun Pharmaceuticals Ltd - Settlement with workers
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that an amicable settlement has been reached with the workers at the Company's Pondicherry API Unit. The strike has been called off and operations resumed from May 25, 2011 morning.
Shasun Pharma Gets US Regulator's Nod for Pain Relief Drug
Business | Press Trust of India | Monday November 16, 2015
Shasun Pharmaceuticals on Monday said it has received approval of the US Food and Drug Administration (FDA) nod to market pain relief drug Carisoprodol in the US.
Strides Arcolab Recovers After Falling Over 5%
Business | Thursday June 18, 2015
Shares of Strides Arcolab slumped 5.4 per cent to Rs 1,090.80 on the BSE after the government rejected a proposal of the pharmaceutical company.
Shasun Pharma, Strides Arcolab Gain on CCI's Nod for Merger
Business | Tuesday March 24, 2015
The combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 15 listed drug makers.
Shasun Gets Investors' Nod for Strides Arcolab Merger
Business | Tuesday March 17, 2015
Shareholders of Shasun Pharmaceuticals have approved its merger proposal with drug firm Strides Arcolab.
Strides Arcolab Gains 11%; Board Approves Merger With Shasun Pharma
Business | Monday September 29, 2014
Under the scheme of merger Shasun Pharmaceuticals will amalgamate with Strides in an all-stock transaction. Shareholder of Shasun Pharmaceuticals will receive 5 equity shares of Strides for every 16 equity shares held by them in Shasun.
Shasun Pharmaceuticals Gains Nearly 30% in Three Days
Business | Thursday May 8, 2014
According to the bulk deal data of NSE, Morgan Stanley Asia (Singapore) PTE bought 402,545 shares for Rs 146.86 per equity share.
Shasun Pharma Acquires Global Rights for Ibuprofen from ScolorPharma
Business | Monday May 5, 2014
The acquisition also includes the controlled release technology of Ibuprofen 12-hour extended release OTC, the company said in a statement.
Ascent Capital buys minority stake in Alivira Animal Health
Business | Wednesday April 16, 2014
Shasun Pharmaceuticals on Wednesday said private equity investor Ascent Capital Advisors India has acquired a minority stake in Alivira Animal Health, a JV firm in which the company and Sequent Scientific Ltd are partners.
Shasun Pharmaceuticals falls on Vertex drug warning
Business | Thursday December 20, 2012
Shasun Pharmaceuticals declined 6 percent after its Vertex Pharmaceuticals warned on Wednesday its hepatitis C drug Incivek, which is used in conjunction with two other products, can cause serious, potentially fatal skin reactions.
SHASUN PHARMACEUTICALS LTD. - Notice of Postal Ballot
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that members of the Company will consider the resolutions by way of Postal Ballot.
Shasun Pharmaceuticals Limited - Change in Directorate
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that the following changes in the Board of Directors of the Company with effective from August 19, 2011; 1. Mr. Tapan Ray, Independent Director & Mr. V. F. Banaji, Independent Director have resigned. 2. Mr. N. Subramanian is inducted as independent Director. 3. Mr. M. Mohan is inducted as Wholetime Di...
Shasun Pharmaceuticals Limited - Outcome of Board Meeting
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 19, 2011, decided to issue and allot 15,00,000 warrants on preferential basis to Promoters / Promoter Group(s) and Directors with each warrant convertible into one equity share of the Company as per the SEBI Guidelines and subject to...
Shasun Pharmaceuticals Ltd - Fixes Book Closure for Dividend & AGM
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 22, 2011 to July 29, 2011 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on July 29, 2011.
Shasun Pharmaceuticals Ltd - Change in Directorate
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that Mr. A. Mahendran has resigned from the Directorship of the Company and Mr. R Sundara Rajan is appointment as Director with effect from May 30, 2011. The changes have been recorded and approved at the Board of Directors' Meeting held on May 30, 2011.
Shasun Pharmaceuticals Ltd - Settlement with workers
Business | NDTV Correspondent | Saturday November 26, 2011
Shasun Pharmaceuticals Ltd has informed BSE that an amicable settlement has been reached with the workers at the Company's Pondicherry API Unit. The strike has been called off and operations resumed from May 25, 2011 morning.
................................ Advertisement ................................
................................ Advertisement ................................
